NCT06670079

Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of Vermont · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is: Does PE+ decrease PTSD symptoms? All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning. Participants will: * Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.

Conditions

• Posttraumatic Stress Disorder
• Pregnancy

Interventions

Type	Name	Description
BEHAVIORAL	Prolonged exposure therapy + incentives for therapy session attendance	Prolonged exposure therapy plus incentives for therapy session attendance

Timeline

• Start date: 2025-12-01
• Primary completion: 2026-11-30
• Completion: 2027-04-30
• First posted: 2024-11-01
• Last updated: 2025-11-25

Locations

1 site across 1 country: United States